These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 36539655)
21. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review. Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187 [TBL] [Abstract][Full Text] [Related]
22. COVID-19, cytokines, inflammation, and spices: How are they related? Kunnumakkara AB; Rana V; Parama D; Banik K; Girisa S; Henamayee S; Thakur KK; Dutta U; Garodia P; Gupta SC; Aggarwal BB Life Sci; 2021 Nov; 284():119201. PubMed ID: 33607159 [TBL] [Abstract][Full Text] [Related]
23. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation. Li S; Zhang Y; Guan Z; Li H; Ye M; Chen X; Shen J; Zhou Y; Shi ZL; Zhou P; Peng K Signal Transduct Target Ther; 2020 Oct; 5(1):235. PubMed ID: 33037188 [TBL] [Abstract][Full Text] [Related]
24. Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm. Torabi-Rahvar M; Rezaei N Curr Pharm Des; 2021; 27(13):1549-1552. PubMed ID: 33238863 [TBL] [Abstract][Full Text] [Related]
25. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants. Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303 [TBL] [Abstract][Full Text] [Related]
26. A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection. Ahmed F Front Immunol; 2020; 11():590459. PubMed ID: 33362771 [TBL] [Abstract][Full Text] [Related]
28. Before the "cytokine storm": Boosting efferocytosis as an effective strategy against SARS-CoV-2 infection and associated complications. Dutta S; Mukherjee A; Nongthomba U Cytokine Growth Factor Rev; 2022 Feb; 63():108-118. PubMed ID: 35039221 [TBL] [Abstract][Full Text] [Related]
29. Hypoxemia and Cytokine Storm in COVID-19: Clinical Implications. Machado C; González-Quevedo A MEDICC Rev; 2021; 23(3-4):54-59. PubMed ID: 34516537 [TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 induced liver injury: Incidence, risk factors, impact on COVID-19 severity and prognosis in different population groups. Liatsos GD World J Gastroenterol; 2023 Apr; 29(16):2397-2432. PubMed ID: 37179584 [TBL] [Abstract][Full Text] [Related]
31. Direct or Collateral Liver Damage in SARS-CoV-2-Infected Patients. Lizardo-Thiebaud MJ; Cervantes-Alvarez E; Limon-de la Rosa N; Tejeda-Dominguez F; Palacios-Jimenez M; Méndez-Guerrero O; Delaye-Martinez M; Rodriguez-Alvarez F; Romero-Morales B; Liu WH; Huang CA; Kershenobich D; Navarro-Alvarez N Semin Liver Dis; 2020 Aug; 40(3):321-330. PubMed ID: 32886936 [TBL] [Abstract][Full Text] [Related]
32. Unraveling the Molecular and Cellular Pathogenesis of COVID-19-Associated Liver Injury. Akkiz H Viruses; 2023 May; 15(6):. PubMed ID: 37376587 [TBL] [Abstract][Full Text] [Related]
33. The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast. Almerie MQ; Kerrigan DD Med Hypotheses; 2020 Oct; 143():109883. PubMed ID: 32492562 [TBL] [Abstract][Full Text] [Related]
34. Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets. Kumar V Int Immunopharmacol; 2020 Dec; 89(Pt B):107087. PubMed ID: 33075714 [TBL] [Abstract][Full Text] [Related]
35. Regulated necrosis in COVID-19: A double-edged sword. Sun C; Han Y; Zhang R; Liu S; Wang J; Zhang Y; Chen X; Jiang C; Wang J; Fan X; Wang J Front Immunol; 2022; 13():917141. PubMed ID: 36090995 [TBL] [Abstract][Full Text] [Related]
36. SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages. Pantazi I; Al-Qahtani AA; Alhamlan FS; Alothaid H; Matou-Nasri S; Sourvinos G; Vergadi E; Tsatsanis C Front Immunol; 2021; 12():683800. PubMed ID: 34248968 [TBL] [Abstract][Full Text] [Related]
37. Potential usefulness of pentoxifylline, a non-specific phosphodiesterase inhibitor with anti-inflammatory, anti-thrombotic, antioxidant, and anti-fibrogenic properties, in the treatment of SARS-CoV-2. González-Pacheco H; Amezcua-Guerra LM; Sandoval J; Arias-Mendoza A Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7494-7496. PubMed ID: 32706089 [TBL] [Abstract][Full Text] [Related]
38. Anti-inflammatory and anti-COVID-19 effect of a novel polyherbal formulation (Imusil) via modulating oxidative stress, inflammatory mediators and cytokine storm. Ratheesh M; Sunil S; Sheethal S; Jose SP; Sandya S; Ghosh OSN; Rajan S; Jagmag T; Tilwani J Inflammopharmacology; 2022 Feb; 30(1):173-184. PubMed ID: 35075553 [TBL] [Abstract][Full Text] [Related]
39. COVID-19 and cancer: start the resolution! Barksdale C; Kipper FC; Tripathy S; Subbian S; Serhan CN; Panigrahy D Cancer Metastasis Rev; 2022 Mar; 41(1):1-15. PubMed ID: 35190921 [TBL] [Abstract][Full Text] [Related]